Asarina pharma riktkurs
Web27 ago 2024 · Asarina Pharma is a Swedish research and development company focused on chronic diseases associated with the menstrual cycle. Asarina Pharma is developing the drug candidate Sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and menstrual migraine. The Company is conducting a clinical Phase IIb study in PMDD. WebAsarina Pharma is the first company in the world to develop Sepranolone as a medication, patenting a pharmaceutical formulation of Sepranolone in 2010. PMDD was Asarina Pharma’s first lead indication. The company developed Sepranolone, the first therapy specifically developed to treat PMDD, based on the 40 years’ research work of its ...
Asarina pharma riktkurs
Did you know?
WebFind out more about our offering and business, meet our CEO, CFO and CBO as they share our story with investors in Stockholm, Gothenburg and online. Talk to us! please don’t … WebAsarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and...
Web5 apr 2024 · About Asarina Pharma. We are a Swedish biotech company developing Sepranolone for allopregnanolone-induced stress- and compulsivity-driven disorders. … WebAsarina Pharma is developing novel and targeted products to treat women with severe symptoms associated with the menstrual cycle such as premenstrual dysphoric disorder (PMDD), allowing these...
Web7 apr 2024 · ASAP, Asarina Pharma, (SE0011641794) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. WebLeggi il nostro grafico in tempo reale per il titolo Asarina Pharma (ASAPH). Scopri tutti i dati in un solo grafico.
WebAsarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders. …
WebAsarina Pharma AB is a Swedish biotech company, which is engaged in developing Sepranolone for allopregnanolonerelated stress, menstrual and neurological disorders. The company was founded by... shopify no meetingsWebTrova l’ultima quotazione dei titoli di Asarina Pharma AB (APS.BE), cronologia, notizie e altre informazioni essenziali per scambiare titoli e investire al meglio. shopify node apiWeb27 feb 2024 · Asarina Pharma AB ha riportato i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2024. Per l'intero anno, l'azienda ha registrato una perdita netta di 13,28 milioni di corone... 5 aprile 2024 shopify no shipping methodWebThe Capital Region of Denmark (Region Hovedstaden) has now given official approval to Asarina Pharma to begin its phase IIa study in Tourette, following a four-month delay due to an administrative backlog The phase IIa Tourette study will take place at the Danish National Center for Tourette at Herlev University Hospital, Scandinavia’s largest … shopify niche storeWebAsarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders. Our … shopify nichesWebASARINA PHARMA AB (PUBL): prezzi di Borsa, grafici, quotazioni, consigli di Borsa, dati finanziari, analisi e notizie in tempo reale dell'azione ASARINA PHARMA AB (PUBL) … shopify non profit pricingWeb15 mar 2024 · About Asarina Pharma We are a Swedish biotech company developing Sepranolone for allopregnanolone-related stress, menstrual and neurological disorders. Our product pipeline is built on over 40 years of research into allopregnanolone-related neurological disorders. shopify norge